Xperix Amends Stock Option Grant Report Reduces Shares to 440,000 Due to Retirements

An amendment to the stock option grant report originally approved by the board on November 23, 2023 was filed on July 22, 2026.
The amendment reflects a reduction in grantees from 43 to 41 and a decrease in shares from 454,000 to 440,000 due to employee retirements.
This is an administrative adjustment reducing the scale of the existing grant with no new capital raising or additional dilution. The current stock price of 2,110 KRW remains well below the exercise price of 3,654 KRW, keeping the options deeply out of the money.
[AI Summary]This amendment is a routine administrative update reflecting retirements and has negligible financial impact. Given the low likelihood of option exercise due to the unfavorable strike price versus current market price, shareholder value is not materially affected.